Adeno-associated virus (AAV)–mediated gene therapy has emerged as a promising treatment for hemophilia B. Data on safety and durability from 13 years of follow-up in a cohort of patients who had been ...
Startup Zilliz Inc., best known as the creator of the Milvus vector database, announced today it has raised $60 million through an extension to its earlier $43 million Series B round of funding.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results